Daar is verskeie behandelingsopsies beskikbaar vir prostaatkanker, afhangende van die stadium en aggressiviteit van die kanker, sowel as die pasiënt se algemene gesondheid en persoonlike voorkeure.
Sommige algemene behandelings sluit in:
1. Aktiewe toesig: Hierdie benadering behels om die kanker noukeurig te monitor deur middel van gereelde ondersoeke en toetse, eerder as om onmiddellik met behandeling te begin.
Dit kan geskik wees vir mans met lae-risiko prostaatkanker.
2. Chirurgie: 'n Prostatektomie is 'n chirurgiese prosedure om die prostaatklier te verwyder.
Dit kan gedoen word deur middel van oop chirurgie of laparoskopies (met behulp van klein insnydings en gespesialiseerde gereedskap).
3. Bestralingsterapie: Hierdie behandeling gebruik hoog-energie bestraling om kanker selle dood te maak.
Dit kan ekstern (van 'n masjien buite die liggaam) of intern (deur implantate wat naby die gewas geplaas word) afgelewer word.
4. Hormonale terapie: Hierdie behandeling verminder die vlakke van manlike hormone (androgene) in die liggaam, wat die groei van prostaatkanker kan vertraag of stop.
Dit kan alleen of in kombinasie met ander behandelings gebruik word.
5. Chemoterapie: Hierdie behandeling gebruik dwelms om kankerselle dood te maak.
Dit kan gebruik word vir gevorderde prostaatkanker wat na ander dele van die liggaam versprei het.
6. Immunoterapie: Hierdie behandeling help die immuunstelsel om kanker te beveg.
Dit kan gebruik word vir gevorderde prostaatkanker wat nie op ander behandelings gereageer het nie.
7. Gerigte terapie: Hierdie behandeling is gerig op spesifieke gene of proteïene wat kanker selle help om te groei en te oorleef.
Dit kan gebruik word vir gevorderde prostaatkanker wat nie op ander behandelings gereageer het nie.
8. Kryoterapie: Hierdie behandeling gebruik uiterste koue om kanker selle te vries en dood te maak.
Dit kan gebruik word vir vroeë stadium prostaatkanker of vir kanker wat na ander behandelings teruggekeer het.
9. Hoë-intensiteit gefokusde ultraklank (HIFU): Hierdie behandeling gebruik hoëfrekwensie klankgolwe om kanker selle te verhit en te vernietig.
Dit kan gebruik word vir vroeë stadium prostaatkanker of vir kanker wat na ander behandelings teruggekeer het.
10. Waaksaam wag: Hierdie benadering behels dat die kanker noukeurig gemonitor word met gereelde ondersoeke en toetse, maar dat behandeling nie begin word tensy simptome verskyn of verander nie.
Dit kan geskik wees vir ouer mans met stadig groeiende prostaatkanker en ander ernstige gesondheidstoestande.
Dit is belangrik om alle behandelingsopsies met 'n gesondheidsorgspan te bespreek om die beste aksie vir elke individuele geval te bepaal.
Wang Y, Chen J, Wu Z, Ding W, Gao S, Gao Y, Xu C: Mechanisms of enzalutamide resistance in castration-resistant prostate cancer and therapeutic strategies to overcome it. Br J Pharmacol. 2021, 178 (2): 239-261.
Talkar SS, Patravale VB: Gene Therapy for Prostate Cancer: A Review. Endocr Metab Immune Disord Drug Targets. 2021, 21 (3): 385-396.
Šamija I, Fröbe A: CHALLENGES IN MANIPULATING IMMUNE SYSTEM TO TREAT PROSTATE CANCER. Acta Clin Croat. 2019, 58 (Suppl 2): 76-81.
Akaza H, Hinotsu S, Usami M, Ogawa O, Kagawa S, Kitamura T, Tsukamoto T, Naito S, Hirao Y, Murai M, Yamanaka H, Namiki M: The case for androgen deprivation as primary therapy for early stage disease: results from J-CaP and CaPSURE. J Urol. 2006, 176 (6 Pt 2): S47-9.
Abraham-Miranda J, Awasthi S, Yamoah K: Immunologic disparities in prostate cancer between American men of African and European descent. Crit Rev Oncol Hematol. 2021, 164 (): 103426.
de Vrij J, Willemsen RA, Lindholm L, Hoeben RC, Bangma CH, Barber C, Behr JP, Briggs S, Carlisle R, Cheng WS, Dautzenberg IJ, de Ridder C, Dzojic H, Erbacher P, Essand M, Fisher K, Frazier A, Georgopoulos LJ, Jennings I, Kochanek S, Koppers-Lalic D, Kraaij R, Kreppel F, Magnusson M, Maitland N, Neuberg P, Nugent R, Ogris M, Remy JS, Scaife M, Schenk-Braat E, Schooten E, Seymour L, Slade M, Szyjanowicz P, Totterman T, Uil TG, Ulbrich K, van der Weel L, van Weerden W, Wagner E, Zuber G: Adenovirus-derived vectors for prostate cancer gene therapy. Hum Gene Ther. 2010, 21 (7): 795-805.
Lee E, Ha S, Logan SK: Divergent Androgen Receptor and Beta-Catenin Signaling in Prostate Cancer Cells. PLoS One. 2015, 10 (10): e0141589.
Verwerping van verantwoordelikheid: mediese
Hierdie webwerf word slegs vir opvoedkundige en inligtingsdoeleindes verskaf en vorm nie die verskaffing van mediese advies of professionele dienste nie.
Die inligting wat verskaf word, moet nie gebruik word om 'n gesondheidsprobleem of siekte te diagnoseer of te behandel nie, en diegene wat persoonlike mediese advies soek, moet 'n gelisensieerde dokter raadpleeg.
Let asseblief daarop dat die neurale netwerk wat antwoorde op die vrae genereer, veral onakkuraat is wanneer dit kom by numeriese inhoud. Byvoorbeeld, die aantal mense wat met 'n spesifieke siekte gediagnoseer is.
Soek altyd die advies van jou dokter of ander gekwalifiseerde gesondheidsorgverskaffer oor 'n mediese toestand. Moet nooit professionele mediese advies ignoreer of vertraag om dit te soek as gevolg van iets wat jy op hierdie webwerf gelees het nie. As jy dink jy kan 'n mediese noodgeval hê, bel 911 of gaan onmiddellik na die naaste noodkamer. Geen dokter-pasiënt verhouding word geskep deur hierdie webwerf of die gebruik daarvan nie. Nie BioMedLib of sy werknemers, of enige bydraer tot hierdie webwerf, maak enige voorstellings, uitdruklik of implisiet, met betrekking tot die inligting wat hierin verskaf word of die gebruik daarvan.
Verwerping van verantwoordelikheid: kopiereg
Die Digital Millennium Copyright Act van 1998, 17 U.S.C. § 512 (die DMCA) bied hulp vir kopiereg eienaars wat glo dat materiaal wat op die Internet verskyn, hul regte onder die Amerikaanse kopiereg wet oortree.
As u in goeie trou glo dat enige inhoud of materiaal wat in verband met ons webwerf of dienste beskikbaar gestel word, u kopiereg oortree, kan u (of u agent) vir ons 'n kennisgewing stuur om te versoek dat die inhoud of materiaal verwyder word, of toegang daartoe geblokkeer word.
Kennisgewings moet skriftelik per e-pos gestuur word (sien afdeling "Kontak" vir e-posadres).
Die DMCA vereis dat u kennisgewing van beweerde inbreuk op outeursreg die volgende inligting bevat: (1) beskrywing van die kopieregbeskermde werk wat die onderwerp van beweerde inbreuk is; (2) beskrywing van die beweerde inbreuk op inhoud en inligting wat genoeg is om ons in staat te stel om die inhoud op te spoor; (3) kontakinligting vir u, insluitend u adres, telefoonnommer en e-posadres; (4) 'n verklaring deur u dat u op 'n goeie geloof glo dat die inhoud op die manier waarop u gekla het nie deur die outeursreg eienaar, of sy agent, of deur die werking van enige wet gemagtig is nie;
(5) 'n verklaring deur u, onderteken onder strawwe van meineed, dat die inligting in die kennisgewing akkuraat is en dat u die gesag het om die outeursregte wat beweer word, af te dwing;
en (6) 'n fisiese of elektroniese handtekening van die outeursreg-eienaar of 'n persoon wat gemagtig is om namens die outeursreg-eienaar op te tree.
As u nie al die bogenoemde inligting insluit nie, kan dit lei tot 'n vertraging in die verwerking van u klag.
Kontak
Stuur asseblief vir ons 'n e-pos met enige vrae / voorstelle.
How to treat prostate cancer?
There are several treatment options available for prostate cancer, depending on the stage and aggressiveness of the cancer, as well as the patient's overall health and personal preferences.
Some common treatments include:
1. Active surveillance: This approach involves closely monitoring the cancer with regular checkups and tests, rather than immediately starting treatment.
It may be suitable for men with low-risk prostate cancer.
2. Surgery: A prostatectomy is a surgical procedure to remove the prostate gland.
It can be done through open surgery or laparoscopically (using small incisions and specialized tools).
3. Radiation therapy: This treatment uses high-energy radiation to kill cancer cells.
It can be delivered externally (from a machine outside the body) or internally (through implants placed near the tumor).
4. Hormone therapy: This treatment reduces the levels of male hormones (androgens) in the body, which can slow or stop the growth of prostate cancer.
It can be used alone or in combination with other treatments.
5. Chemotherapy: This treatment uses drugs to kill cancer cells.
It may be used for advanced prostate cancer that has spread to other parts of the body.
6. Immunotherapy: This treatment helps the immune system fight cancer.
It may be used for advanced prostate cancer that has not responded to other treatments.
7. Targeted therapy: This treatment targets specific genes or proteins that help cancer cells grow and survive.
It may be used for advanced prostate cancer that has not responded to other treatments.
8. Cryotherapy: This treatment uses extreme cold to freeze and kill cancer cells.
It may be used for early-stage prostate cancer or for cancer that has come back after other treatments.
9. High-intensity focused ultrasound (HIFU): This treatment uses high-frequency sound waves to heat and destroy cancer cells.
It may be used for early-stage prostate cancer or for cancer that has come back after other treatments.
10. Watchful waiting: This approach involves closely monitoring the cancer with regular checkups and tests, but not starting treatment unless symptoms appear or change.
It may be suitable for older men with slow-growing prostate cancer and other serious health conditions.
It is important to discuss all treatment options with a healthcare team to determine the best course of action for each individual case.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
Ongeveer
BioMedLib gebruik outomatiese rekenaars (masjienleeralgoritmes) om vraag-en-antwoord-pare te genereer.
Ons begin met 35 miljoen biomediese publikasies van PubMed/Medline. Ook webbladsye van RefinedWeb.
Sien "Referensies" ook "Verwerping van aanspreeklikheid".
